热点
"RNAi疗法" 相关文章
Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension
INVESTOR 2025-09-29T02:49:42.000000Z
认知颠覆战，当Alnylam逼近4000亿
36kr 2025-08-03T23:42:01.000000Z